Financials

  • Market Capitalization 45.18 M
  • Employee 1
  • Founded 1998
  • CEO N/A
  • Website www.alaunos.com
  • Headquarter Delaware, United States
  • FIGI BBG000FWCC57
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.47
Price to sales ratio
1 258.64

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4270
ATYR
aTyr Pharma, Inc. - Common Stock
0.48 USD0.00%0.00%-20.00%-50.52%47.06 M USD
4271
INMB
INmune Bio Inc. - Common stock
1.77 USD+4.73%+3.51%+9.26%-30.04%47.06 M USD
4284
TCRX
TScan Therapeutics, Inc. - Common Stock
0.74 USD-2.63%-9.76%-25.25%-56.47%45.19 M USD
4288
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.22 USD0.00%+0.83%+4.27%-15.28%45.93 M USD

Frequently asked questions about Alaunos Therapeutics, Inc. - Common Stock

What is the Alaunos Therapeutics, Inc. - Common Stock stock price today?

The current price of Alaunos Therapeutics, Inc. - Common Stock (TCRT) is 1.85. Over the past 24 hours, the stock has changed by -1.60%. Follow the TCRT chart for real-time price dynamics.

What is the stock ticker of Alaunos Therapeutics, Inc. - Common Stock?

Alaunos Therapeutics, Inc. - Common Stock trades under the ticker TCRT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Alaunos Therapeutics, Inc. - Common Stock stock going up?

TCRT has changed by -4.64% over the last week, -18.50% over the last month, and -30.69% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Alaunos Therapeutics, Inc. - Common Stock?

Alaunos Therapeutics, Inc. - Common Stock currently has a market capitalization of 45.18 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Alaunos Therapeutics, Inc. - Common Stock earnings last quarter?

Last quarter, Alaunos Therapeutics, Inc. - Common Stock reported earnings of -0.59 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Alaunos Therapeutics, Inc. - Common Stock revenue for the last quarter?

Alaunos Therapeutics, Inc. - Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Alaunos Therapeutics, Inc. - Common Stock net income for the last quarter?

Alaunos Therapeutics, Inc. - Common Stock reported net income of -1.01 M for the last quarter. The previous quarter showed -893 K, which means net income changed by -12.65%.

How many employees does Alaunos Therapeutics, Inc. - Common Stock have?

As of the latest available data, Alaunos Therapeutics, Inc. - Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Alaunos Therapeutics, Inc. - Common Stock stock?

You can buy Alaunos Therapeutics, Inc. - Common Stock (TCRT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Alaunos Therapeutics, Inc. - Common Stock stock?

Investing in Alaunos Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TCRT chart and related analysis on metatrader.com as part of your research.

News